Atea Pharmaceuticals Inc (AVIR)
3.73
+0.06
(+1.63%)
USD |
NASDAQ |
Apr 23, 16:00
3.73
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
Date | Value |
---|---|
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
--
Maximum
Dec 2020
--
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.00 |
IGC Pharma Inc | 0.0152 |
NovaBay Pharmaceuticals Inc | 0.3431 |
Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 594.97M |
Total Liabilities (Quarterly) | 39.78M |
Shareholders Equity (Quarterly) | 555.19M |